Procter & Gamble Product Vicks Action 500 is Banned in India
Procter & Gamble (P & G) products Vicks Action 500 additional stops sales after government restrictions
Fast moving consumer goods company Procter & Gamble (P & G) of the building and Vicks Action 500 additional drugs “FDCs its popular brand ‘immediately after the government banned the sale stopped.
Indian Governments follows the Drugs rule Properly
“The government of India selling drugs and fixed-dose combination (Paracetamol + phenylephrine + caffeine) have been banned with immediate effect for the development of distribution,” Pfizer said in a statement to the Bombay Stock Exchange.
He added: ” ‘Vicks further action 500’ Procter & Gamble products and fixed dose combination is covered by the manufacture and SKUs of Vicks Action 500 notification is closed with immediate effect additional sales.
Others restrict the manufacture, sale and used in cough syrups containing codeine syrup chlorpheniramine maleate without fixed-dose combination of the distribution between the Governments was in a gazette notification on March 10.
On Monday, the biggest drug from Pfizer and Abbott, respectively, of its popular cough syrup Corex and Phensedyl sale closes, the government fixed dose combination 300 (CDF) of banned drugs.
Both companies, however, said that “all options” are explored to counter the effects of the ban.
Pfizer said sales of its Corex cough syrup has stopped the sale of Rs. 176 million in the nine months ended Dec. 31 and that the measure will have an adverse effect on him.
“The company is exploring all options available at your disposal … the prohibition of revenues and profitability of the company is likely to have an adverse effect,” Pfizer said in a statement to the Bombay Stock Exchange.
Given the government ban the manufacture and sale of Corex, “the company has stopped production and sale of the drug with immediate effect said ‘Corex’ Pfizer in India for more Corex and a well established efficacy said the safety profile 30 years.
Abbott has also stopped selling Phensedyl cough syrup.
Contacted he said a company spokesman of Procter & Gamble, “Abbott met all legal requirements regarding notification that the government is”.
Procter & Gamble “to prohibit certain drug fixed-dose combination that have already been approved” a “unilateral” approach as described in the decision of the Ministry of Health.
“Abbott DCGI reviewing the notice and the production, sale and certain combinations of doses that have already been approved for use by DCGI prohibiting distribution are concerned about the unilateral approach. We assess Notification and are looking for all available options,” he said spokesman.
Some of these formulations in specific medical conditions has been the treatment of choice, Abbott said.